Imatinib Mesylate Does Not Inhibit BCR-ABL Kinase Activity in CML Stem Cells In Vitro.
Year: 2004
Type: article
Source: Blood
Institutions: Oregon Health & Science University, University of Glasgow
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2980236806
